Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Oncology

NewLink Genetics and Roche have teamed up to develop NewLink’s cancer immunothereapy in a $1 billion deal, Reuters reports. The NewLink inhibitor, NLG919, works to disrupt the process through which tumors elude a patient’s immune system....
An experimental T-Cell therapy which genetically programs a patient’s cells to fight disease is showing promise in bringing remission to leukemia patients, The New York Times reports. According to a study published in The New England Journal of...
According to an article published by CBS News, a new device can help patients with cancer keep their hair during chemotherapy. Dignitana‘s DigniCap, which is worn by patients during chemotherapy treatment, cools the scalp down to 5 degrees...